This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Parkin DM et al. (eds) Cancer incidence in five continents, Vols VI–VIII. Lyon: IARC Publication numbers 120 (1992), 143 (1997) and 155 (2002)
Skates SJ et al. (2003) Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J Clin Oncol 21 (Suppl): 206–210
Chan JK et al. (2003) Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important? Obstet Gynecol 102: 156–161
Gershenson DM et al. (1990) Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 8: 715–720
Williams S et al. (1994) Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol 12: 701–706
Boyd J et al. (2000) Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA 283: 2260–2265
Acknowledgements
The synopsis was written by Alexandra King, Assistant Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Brewster, W. Temporal trends in ovarian cancer: incidence and mortality across Europe. Nat Rev Clin Oncol 2, 286–287 (2005). https://doi.org/10.1038/ncponc0198
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0198